DRESS syndrome, a drug reaction which remains bad known from pediatricians

被引:9
作者
Autret-Leca, E. [1 ]
Norbert, K. [2 ]
Bensouda-Grimaldi, L. [1 ]
Jonville-Bera, A. -P. [1 ]
Saliba, E. [2 ]
Bentata, J. [3 ]
Barthez-Carpentier, M. -A. [4 ]
机构
[1] CHRU Tours, Hop Bretonneau, Ctr Reg Pharmacovigilance & Informat Medicament, Serv Pharmacol, F-37044 Tours 09, France
[2] CHRU Tours, Hop Gatien de Clocheville, Serv Reanimat Pediat & Neonatol, F-37044 Tours 09, France
[3] CHR Orleans, Hop Porte Madeleine, Serv Peidat Gen, F-45000 Orleans, France
[4] CHRU Tours, Hop Gatien de Clocheville, Serv Neurochirurg & Neurol, F-37044 Tours 09, France
来源
ARCHIVES DE PEDIATRIE | 2007年 / 14卷 / 12期
关键词
D O I
10.1016/j.arcped.2007.07.016
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The DRESS syndrome (Rash with Eosinophilia and Systemic Symptoms) is a drug hypersensitivity reaction poorly known by paediatricians. It occurs within 1 to 8 weeks of treatment. Clinical features associate in variable patterns, fever, rash, lymphadenopathies, arthritis and potentially life-threatening damage (hepatitis, nephritis, pneumonitis), hyperleucocytosis and eosinophilia. This condition must be early recognized in order to immediately stop suspect drugs. A 6.5 year old girl had a febrile rash, hyperleucocytosis, lymph nodes and cytolitic hepatitis probably due to phenobarbital. Diagnosis of DRESS syndrome was performed only 13 days after the beginning of the eruption. Evolution was favorable but characterized by the recurrence of the febrile eruption with pleuritis. DRESS syndrome is a well described disease that occurs during treatment with a number drugs, particularly anti-epileptic drugs. Steroid therapy and immunoglobulins are proposed for treatment but have not been evaluated. (c) 2007 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:1439 / 1441
页数:3
相关论文
共 19 条
[1]   Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus [J].
Aihara, M ;
Sugita, Y ;
Takahashi, S ;
Nagatani, T ;
Arata, S ;
Takeuchi, K ;
Ikezawa, Z .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) :1231-1234
[2]   Antiepileptic drug hypersensitivity syndrome in a patient treated with valproate [J].
Arévalo-Lorido, JC ;
Carretero-Gómez, J ;
Bureo-Dacal, JC ;
Montero-Leal, C ;
Bureo-Dacal, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) :415-416
[3]   Anticonvulsant hypersensitivity syndrome: Lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment [J].
Bavdekar, SB ;
Muranjan, MN ;
Gogtay, NJ ;
Kantharia, V ;
Kshirsagar, NA .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (10) :1648-1650
[4]   CROSS-REACTIVE SKIN ERUPTION WITH BOTH CARBAMAZEPINE AND OXCARBAZEPINE [J].
BERAN, RG .
EPILEPSIA, 1993, 34 (01) :163-165
[5]  
Bessmertny O, 2001, ANN PHARMACOTHER, V35, P533
[6]   Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) [J].
Bocquet, H ;
Bagot, M ;
Roujeau, JC .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 1996, 15 (04) :250-257
[7]   Oxcarbazepine and DRESS syndrome: a paediatric cause of acute liver failure [J].
Bosdure, E ;
Cano, A ;
Roquelaure, B ;
Reynaud, R ;
Boyer, A ;
Viard, L ;
Sarles, J .
ARCHIVES DE PEDIATRIE, 2004, 11 (09) :1073-1077
[8]   Drug-induced hypersensitivity syndrome in pediatric patients [J].
Carroll, MC ;
Yueng-Yue, NB ;
Esterly, NB ;
Drolet, BA .
PEDIATRICS, 2001, 108 (02) :485-493
[9]  
Descamps V, 2001, ARCH DERMATOL, V137, P301
[10]  
Ghislain Pierre-Dominique, 2002, Dermatol Online J, V8, P5